Title | Credit | Series date | Member price |
Non-member price![]() |
---|---|---|---|---|
3-PARRT 2023: Human Trafficking 102 0.5 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate of $0 to NAPNAP Members. For non-members, this continuing education activity rate is $10. This course is intended to help health care providers understand the nature of human trafficking with a focus on the pediatric population. Module 102 of the 3-PARRT series reviews the encounter of the trafficked or potentially trafficked patient in the clinical environment. We will discuss patient/provider barriers, how to approach the trafficked patient, history taking, review of systems, and physical assessment. We'll also go over maintaining safety for all involved, proper documentation of the encounter, and trauma informed care. |
|
05/25/2023 to 05/31/2025 | $0.00 | $10.00 |
JPHC CE: Secondhand Smoke Exposure in Pediatric Patients: What Is the Nurse Practitioner’s Role? 0.75 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. The detrimental impact of smoking is extensively known and documented. However, what about those who cannot make that choice for themselves? Unlike most adults, children have little to no control over their environment, relying heavily on the choices and actions of their parent(s). While this is true with various factors, it is especially true with secondhand smoke exposure (SHSe). No amount of smoke is a safe level to be around, especially in infancy and childhood. The American Academy of Pediatrics (AAP) defines secondhand smoke (SHS) as “smoke emitted from a tobacco product or exhaled from a person who smokes that is inhaled by a person who does not smoke,” enveloping involuntary participants like infants and children (Jenssenetal.,2023). This continuing education paper strives to give insight into the dangers of SHSe for children, a guide for providers, and resources for parent(s) struggling with tobacco dependency. J Pediatr Health Care. (2024) 38, Issue 6, 936-942. |
|
11/01/2024 to 12/31/2025 | $0.00 | $10.00 |
JPHC CE: Diagnosis and Management of Pediatric Allergic Rhinoconjunctivitis in the US 1.0 NAPNAP contact hour of which 0.5 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Allergic rhinoconjunctivitis (AR/C) is a common pediatric condition. The physical, emotional, and social burden of AR/C in children highlights the need for accurate diagnosis with optimal treatment. This review provides practical information on the diagnosis and management of pediatric AR/C. Key features of the patient history and physical exam needed to diagnose seasonal and perennial AR/C are covered. Various AR/C treatment options are reviewed such as allergen avoidance, pharmacotherapies, and allergy immunotherapy (both subcutaneous injections and sublingual tablets) as well as their mode of action, side effects, and their role in guideline-recommended therapy. Practical information such as pollen calendars, management algorithms, and treatment product characteristics have also been included in this review. J Pediatr Health Care. (2025) 39, 489-502. |
|
05/01/2025 to 06/30/2026 | $0.00 | $10.00 |
JPHC CE: Child Sexual Abuse Victimization and Parenting 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Pediatric nurse practitioners (PNPs) care for children who have experienced sexual abuse or are being parented by a sexual abuse survivor, often without PNP awareness of the trauma exposure. It is crucial for PNPs and all pediatric health care providers to understand the relationship between sexual abuse victimization and parenting to better advocate for vulnerable children and their caregivers. This continuing education article will explore sexual abuse victimization and its’ potential impact on adults who parent with a focus on implications for practice. |
|
04/16/2024 to 06/30/2025 | $0.00 | $10.00 |
JPHC CE: The Resurgence of Syphilis: A Critical Public Health Concern 1.25 NAPNAP contact hour of which 0.5 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Syphilis, a sexually transmitted infection caused by Treponema pallidum, has become a concerning resurgence in recent years, particularly in the United States. Of significant concern is the steep rise in congenital syphilis cases, which poses grave risks to maternal and neonatal health. This article provides an overview of the epidemiology, risk factors, clinical manifestations, screening methods, and treatment strategies for syphilis, with a specific focus on congenital transmission. Drawing upon current literature and guidelines, the paper underscores the importance of early detection and intervention to prevent adverse outcomes associated with congenital syphilis. Furthermore, the article highlights the challenges in syphilis diagnosis, including the interpretation of serological tests and the management of neurosyphilis. Recommendations for practice, including screening protocols and treatment regimens, are discussed in detail. The conclusion emphasizes the urgent need for collaborative efforts among healthcare providers, public health agencies, and community stakeholders to address the syphilis epidemic effectively. By adhering to evidence-based guidelines and leveraging available resources, clinicians can play a pivotal role in reducing the burden of syphilis and safeguarding the health of vulnerable populations, particularly pregnant women and infants. J Pediatr Health Care. (2025) 39, 479-488. |
|
05/01/2025 to 06/30/2026 | $0.00 | $10.00 |
JPHC CE: Preventing HIV in the Adolescent Population with PrEP: The Role of the Nurse Practitioner 1.0 NAPNAP contact hour of which 1.0 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Preexposure prophylaxis (PrEP) uptake remains low among adolescents and young adults at high risk due to various barriers, such as decreased access to care, human immunodeficiency virus (HIV) stigma, and misinformation. The barriers to the uptake of PrEP among adolescents and young adults are multifaceted and require comprehensive mitigation strategies. Presented is the epidemiology of HIV, pathophysiology, and complications of HIV in adolescents, history of PrEP research, “How to End the HIV Epidemic in the U.S.” plan, reviewing and eliminating barriers to PrEPcare, PrEP curriculum opportunities for the provider, and the role of the nurse practitioner in reducing new HIV diagnoses in adolescents. J pediatr Health Care. (2025) 39, 503−514. |
|
05/01/2025 to 06/30/2026 | $0.00 | $10.00 |
Addressing Challenges in the Recognition and Management of Pediatric Sepsis in the Emergency Department, Critical Care and Post-Sepsis Care 1.0 NAPNAP Contact Hour of which 0.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is a recorded presentation for NAPNAP's 2024 National Conference. Sepsis remains one of the most frequent causes of pediatric morbidity and mortality. This presentation will address challenges in pediatric sepsis recognition and management, as well as provide education regarding care of the septic patient in various settings (e.g., emergency department, critical care, and post-sepsis care). Participants will be introduced to sepsis protocols currently being utilized within institutions across the country. |
|
06/27/2024 to 06/30/2026 | $10.00 | $10.00 |
Addressing Challenges in the Recognition and Management of Pediatric Sepsis in the Emergency Department, Critical Care and Post-Sepsis Care 1.0 NAPNAP Contact Hour of which 0.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is a recorded presentation for NAPNAP's 2024 National Conference. Sepsis remains one of the most frequent causes of pediatric morbidity and mortality. This presentation will address challenges in pediatric sepsis recognition and management, as well as provide education regarding care of the septic patient in various settings (e.g., emergency department, critical care, and post-sepsis care). Participants will be introduced to sepsis protocols currently being utilized within institutions across the country. |
|
06/27/2024 to 06/30/2026 | $10.00 | $10.00 |
JPHC CE: Female Genital Mutilation and Cutting: Essentials for Pediatric Nurse Practitioners 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Female genital mutilation and cutting (FGM/C) is a serious global public health problem, violating the basic human rights of girls and woman. FGM/C is a form of child maltreatment. According to the World Health Organization 200 million girls and women have undergone FGM/C in thirty countries in Africa, the Middle East, and Asia. Studies indicate that healthcare professionals, including nurses and advanced practice registered nurses, report a lack of knowledge and comfort related to the identification and clinical management of FGM/C. It is critical that all healthcare professionals, including pediatric nurse practitioners (PNP), possess a thorough understanding of FGM/C and intervene appropriately. This continuing education article will define FGM/C, describe cultural implications, discuss possible short and long-term consequences, and explore implications for practice. J Pediatr Health Care. (2025) 39, Issue 1, 112-121. |
|
01/01/2025 to 12/31/2025 | $0.00 | $10.00 |
2025 Practice Innovation Posters 0.5 NAPNAP Contact Hours. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $5 for NAPNAP Members. For non-members, this continuing education activity rate is $10. This course is archived practice innovation posters from NAPNAP's 2025 National Conference. |
|
05/08/2025 to 05/31/2027 | $5.00 | $10.00 |
NP Preceptor: Telehealth Interprofessional Practice 0.5 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $5 for NAPNAP Members. For non- members, this continuing education activity rate is $10. This module will introduce telehealth delivered by Nurse Practitioners in the context of a primary care practice. This module introduces the basic concepts of Telehealth Interprofessional Practice. The module takes approximately 30 minutes to complete and you may complete it at your own pace. Pre-Test - Please complete the pre-test. It only takes about 3 minutes. Test results are reported as AGGREGATE DATA ONLY for us to evaluate the effectiveness of each learning module. |
|
07/30/2019 to 06/30/2025 | $5.00 | $10.00 |
Addressing Challenges in the Recognition and Management of Pediatric Sepsis in the Emergency Department, Critical Care and Post-Sepsis Care 1.0 NAPNAP Contact Hour of which 0.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is a recorded presentation for NAPNAP's 2024 National Conference. Sepsis remains one of the most frequent causes of pediatric morbidity and mortality. This presentation will address challenges in pediatric sepsis recognition and management, as well as provide education regarding care of the septic patient in various settings (e.g., emergency department, critical care, and post-sepsis care). Participants will be introduced to sepsis protocols currently being utilized within institutions across the country. |
|
06/27/2024 to 06/30/2026 | $10.00 | $10.00 |
JPHC CE: Gene Therapy: A New Hope in Sickle Cell Disease Treatment 1.0 NAPNAP contact hour of which 1.0 contain pharmacology content. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Sickle cell disease (SCD) is a lifelong disease requiring expensive treatment for management and limited curative options until the last few years. Gene therapy has emerged as a curative option for SCD, with two approved therapies available to SCD patients aged greater than 12 years. Consideration must be considered regarding the ethics, efficacy, management requirements, education, and counseling needs of patients and their parents. Current and future practices will need to advocate for improved access and affordability of this specialized care and address the unknown and less defined areas of gene therapy pertaining to SCD through research. J Pediatr Health Care. (2025) 39, Issue 1, 122-128. |
|
01/01/2025 to 02/28/2026 | $0.00 | $10.00 |
Overuse of Psychotropic Medications in Children and Youth in Foster Care 0.5 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $5 for NAPNAP Members. For non- members, this continuing education activity rate is $10. Children in foster care are a vulnerable population with unmet health care needs complicated by a history of trauma, making providing comprehensive care difficult for Advanced Practice Providers (APPs). Care for this population is often transient and crisis centered, and an estimated 80% of children in foster care having one or more psychiatric diagnoses. Despite this rate of psychiatric diagnoses, children in foster care are prescribed psychotropic medications at a disproportionately high rate that is more than twice that of Medicaid controls. Stimulants are the most prescribed medication class followed by atypical anti-psychotic medications. A better understanding of the common mental health diagnoses of children in foster care, common medication indications and their monitoring, and available evidence-based treatments are imperative for APPs to care for this population. APPs need to be strong advocates for this vulnerable population to reduce the risk of psychotropic medication overuse and improve overall health outcomes. |
|
07/05/2023 to 07/31/2025 | $5.00 | $10.00 |
JPHC CE: Approaches to Treating Children With ADHD and Common Comorbidities 1.0 NAPNAP contact hour of which 1.0 contain pharmacology content (Rx), (1.0 is related to psychopharmacology), (0.25 is related to controlled substance). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Attention Deficit Hyperactivity Disorder (ADHD) is the most common mental health disorder among children and adolescents, with a prevalence rate of 9.8% in children 3 to 17 years of age (Bitsko et al., 2022). The American Academy of Pediatrics (AAP) has published guidelines for treatment of ADHD in children and adolescents ages 4 to 17 years that address diagnosis, treatment and monitoring of ADHD (Wolraich et al., 2019). The AAP guidelines do not address treatment of children with co-morbidities but identify the treatment of ADHD in children with comorbidities as an area for future research. To address this gap, a review of ADHD treatment in children with comorbidities including anxiety, depression, substance use disorder (SUD), epilepsy, tic disorders (TD), oppositional defiant disorder (ODD), learning disabilities (LD), autism spectrum disorder (ASD) and sleep disorders was conducted. J Pediatr Health Care. (2025) 39, 318-325. |
|
03/01/2025 to 04/30/2026 | $0.00 | $10.00 |